[Uncertain benefit of low dosage ASA in peripheral arterial disease. Low dosage in symptomatic--individual assessment in asymptomatic disease].
Norgren
Lars
L
Kirurgiska kliniken, Universitetssjukhuset, Orebro. lars.norgren@orebroll.se
Bergqvist
David
D
Pärsson
Håkan
H
D001241:Aspirin / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D055502:Secondary Prevention; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D001241:Aspirin